Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
PHASE2
This phase II/III Expanded Lung-MAP treatment trial compares the effect of ...
Status
Recruiting
Location
Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis
Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)
PHASE2
This phase II Lung-MAP non-Match treatment trial studies how well ramucirum...
Status
Completed
Location
University of South Alabama Mitchell Cancer Institute
As a Second-line Treatment for Metastatic Gastric Adenocarcinoma Patients, the Safety and Effective of Vactosertib Administration in Combination With Paclitaxel+Ramucirumab is Evaluated, and a Phase 2a Clinical Trial to Biomarkers
PHASE2
This clinical trial is to evaluate the efficacy and safety of subjects with...
Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
PHASE2
This phase II/III Lung-MAP trial studies how well immunotherapy treatment w...
Status
Active Not Recruiting
Location
Veterans Administration Medical Center - Birmingham